tiprankstipranks
Trending News
More News >
ONO Pharmaceutical Co Ltd (JP:4528)
:4528
Japanese Market

ONO Pharmaceutical Co (4528) Income Statement

Compare
1 Followers

ONO Pharmaceutical Co Income Statement

Last quarter (Q4 2025), ONO Pharmaceutical Co's total revenue was ¥112.31B, a decrease of -13.34% from the same quarter last year. In Q4, ONO Pharmaceutical Co's net income was ¥-6.54B. See ONO Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 486.87B¥ 502.67B¥ 447.19B¥ 361.36B¥ 309.28B
Gross Profit
¥ 335.47B¥ 372.67B¥ 334.28B¥ 264.91B¥ 221.10B
Operating Expenses
¥ 272.08B¥ 209.10B¥ 181.99B¥ 150.00B¥ 129.00B
Depreciation and Amortization
¥ 26.89B¥ 18.14B¥ 17.45B¥ 17.72B¥ 15.82B
EBITDA
¥ 90.28B¥ 181.70B¥ 169.75B¥ 132.63B¥ 107.92B
Operating Income
¥ 63.38B¥ 163.56B¥ 152.29B¥ 114.91B¥ 92.10B
Other Income/Expenses
¥ -4.06B¥ 173.00M¥ -8.76B¥ -9.89B¥ 8.79B
Pretax Income
¥ 59.33B¥ 163.73B¥ 143.53B¥ 105.03B¥ 100.89B
Net Income
¥ 50.05B¥ 127.98B¥ 112.72B¥ 80.52B¥ 75.42B
Per Share Metrics
Basic EPS
¥ 106.55¥ 266.61¥ 230.85¥ 162.19¥ 151.11
Diluted EPS
¥ 106.41¥ 266.57¥ 230.79¥ 162.16¥ 151.09
Weighted Average Shares Outstanding
469.69M 480.01M 488.30M 496.46M 499.14M
Weighted Average Shares Outstanding (Diluted)
469.77M 480.04M 488.35M 496.53M 499.20M
Currency in JPY

ONO Pharmaceutical Co Earnings and Revenue History